Claims for Patent: 10,696,758

✉ Email this page to a colleague

Summary for Patent: 10,696,758

Title:	Group 4 catalyst compounds and process for use thereof
Abstract:	This invention relates to metallocene compounds having a group substituted at the 3 position of at least one cyclopentadienyl ring represented by the formula —CH2—SiR′3 or —CH2—CR′3 and R′ is a C1 to C20 substituted or unsubstituted hydrocarbyl.
Inventor(s):	Subramaniam Kuppuswamy, Matthew W. Holtcamp, David M. Fiscus, Matthew S. Bedoya, Laughlin G. McCullough, Xuan Ye
Assignee:	ExxonMobil Chemical Patents Inc
Application Number:	US15/877,143

Details for Patent 10,696,758

Glossary

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Janssen Biotech, Inc.	SIMPONI	golimumab	Injection	125289	April 24, 2009	⤷ Start Trial	2038-01-22
Janssen Biotech, Inc.	SIMPONI	golimumab	Injection	125289	May 15, 2013	⤷ Start Trial	2038-01-22
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Approval Date	>Patent No.	>Expiredate

International Patent Family for US Patent 10,696,758

Subscribe to access the full database, or Start Trial
Country	Patent Number	Estimated Expiration
World Intellectual Property Organization (WIPO)	2018151904	⤷ Start Trial
United States of America	2018237559	⤷ Start Trial
Singapore	11201906927P	⤷ Start Trial
South Korea	20190112293	⤷ Start Trial
European Patent Office	3854825	⤷ Start Trial
European Patent Office	3583141	⤷ Start Trial
China	110325561	⤷ Start Trial
>Country	>Patent Number	>Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.